Fukushima: 'ecolab' branding insensitive
As the organizers of a symposium on the genetic effects of radiation following the Fukushima disaster -held at this year's annual meeting of the Society for Molecular Biology and Evolution -we object strongly to the headline of your report 'Fukushima offers real-time ecolab' (Nature 499, 265-266; 2013) .
In our view and those of many others from Japan and elsewhere who have communicated their objections to us, it conveys a lack of empathy among researchers for the suffering of the people and animals affected by the Fukushima power-plant disaster.
Scientists working on the consequences of the catastrophic events of March 2011, including the symposium panellists and ourselves, always take into primary consideration the pain of people in Fukushima. Fukushima: unpaid soil-research effort
We and other particle physicists working voluntarily in Fukushima, Japan, where people were evacuated in 2011 because of the nuclear accident, are neither "opportunistic" nor "adventurous", as you quote (see Nature 499, 265-266; 2013). We seek only to use our expertise to find a way to reduce the Antibiotics: support US policy change
As a microbiologist and member of the US Congress, I applaud your call to action on the overuse of antibiotics in agriculture (Nature 499, 379, 394-396, 398-400; 2013 The only US antibiotic data available are the sales figures that drug companies report to the Food and Drug Administration (FDA), which are published as total sales for each antibiotic class. Such broad aggregated data are of limited value, beyond confirming the extensive use of antibiotics in animals reared for food.
In February 2011, the Center for a Livable Future at the Johns Hopkins University in Baltimore, Maryland, and the Government Accountability Project (GAP) in Washington DC attempted to obtain more detailed antibiotics data from the FDA under the Freedom of Information Act. The FDA denied the request, claiming that these commercial data are confidential. In December 2012, GAP sued the FDA for access to the data (the case is ongoing).
Given that the misuse of antibiotics erodes their efficacy, there is an urgent need for greater transparency over their use. We contend that the FDA, as a public-health agency, is responsible to the public, not to the industry it regulates. It is imperative that more antibiotic data be released so that evidencebased public-health policies can be developed to combat antibiotic resistance. We give up our weekends to work independently on analysing soil samples -a gruelling task in the winter months. We give lectures on radiation to those forced to leave their homes, so that they can better understand their plight and our efforts to remedy it. Our goal is to enable local farmers' livelihoods eventually to be restored. Tokio Kenneth Ohska, Hiroshi Iwase High Energy Accelerator Research Organization, Tsukuba, Japan. hiroshi.iwase@kek.jp 
